Literature DB >> 9473479

Two mutations in rat trypsin confer resistance against autolysis.

E Várallyay1, G Pál, A Patthy, L Szilágyi, L Gráf.   

Abstract

Due to autodigestion the activity of dissolved trypsin successively decreases. Autolysis leads to proteolytic cleavages of some arginyl and lysyl peptide bonds of the trypsin structure. Three important autolysis sites have been reported for bovine trypsin: Lys61-Ser62, Arg117-Val118 and Lys145-Ser146. Out of these three sites only the first two exist in rat trypsin, an enzyme that has been the target of protein engineering for more than ten years. In this work Lys61 and Arg117 were replaced by Asn via site directed mutagenesis to transform the corresponding peptide bonds to trypsin resistant ones. Kinetic parameters of K61N, R117N and the double mutant K61N/R117N are practically identical with those of the wild-type enzyme. By contrast, the rate of autolysis of each singly-substituted species is substantially slower than with the parent trypsin. In particular, the double mutant shows dramatically increased stability against autolysis and decreased sensitivity to Ca2+. The process of autolysis has been followed by N-terminal sequence determination. We propose a model to explain why these two positions play a key role in autolysis and how Ca2+ can influence this process. In addition, our in vitro results strongly support the recently proposed model of human hereditary pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473479     DOI: 10.1006/bbrc.1997.8058

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Hereditary pancreatitis: new insights into acute and chronic pancreatitis.

Authors:  D C Whitcomb
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Biochemical models of hereditary pancreatitis.

Authors:  Miklós Sahin-Tóth
Journal:  Endocrinol Metab Clin North Am       Date:  2006-06       Impact factor: 4.741

Review 3.  Human pancreatic digestive enzymes.

Authors:  David C Whitcomb; Mark E Lowe
Journal:  Dig Dis Sci       Date:  2007-01-05       Impact factor: 3.199

Review 4.  Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Authors:  Niels Teich; Jonas Rosendahl; Miklós Tóth; Joachim Mössner; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

5.  Carbomer inhibits tryptic proteolysis of luteinizing hormone-releasing hormone and N-alpha-benzoyl-L-arginine ethyl ester by binding the enzyme.

Authors:  G F Walker; R Ledger; I G Tucker
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

6.  Conformational flexibility in the catalytic triad revealed by the high-resolution crystal structure of Streptomyces erythraeus trypsin in an unliganded state.

Authors:  Elise Blankenship; Krishna Vukoti; Masaru Miyagi; David T Lodowski
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-22

Review 7.  The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis.

Authors:  Masahiko Hirota; Masaki Ohmuraya; Hideo Baba
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

Review 8.  Genetic background of pancreatitis.

Authors:  Masahiko Hirota; Masaki Ohmuraya; Hideo Baba
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

9.  The histopathology of PRSS1 hereditary pancreatitis.

Authors:  Aatur D Singhi; Reetesh K Pai; Jeffrey A Kant; Tanner L Bartholow; Herbert J Zeh; Kenneth K Lee; Martin Wijkstrom; Dhiraj Yadav; Rita Bottino; Randall E Brand; Jennifer S Chennat; Mark E Lowe; Georgios I Papachristou; Adam Slivka; David C Whitcomb; Abhinav Humar
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

10.  The guinea pig pancreas secretes a single trypsinogen isoform, which is defective in autoactivation.

Authors:  Béla Ozsvári; Péter Hegyi; Miklós Sahin-Tóth
Journal:  Pancreas       Date:  2008-08       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.